The influence of the prebiotic gum acacia on the intestinal microbiome composition in rats with experimental chronic kidney disease

[Display omitted] •First report, which examine the effect of GA on gut microbiota in adenine-induced CKD.•Reno-protective effect of GA through the improvement of gut microbial dysbiosis.•GA supplementation increased the butyrate level in adenine-induced CKD animal model.•GA modulated Actinobacteria,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biomedicine & pharmacotherapy 2021-01, Vol.133, p.110992, Article 110992
Hauptverfasser: Lakshmanan, Arun Prasath, Al Za’abi, Mohammed, Ali, Badreldin H, Terranegra, Annalisa
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:[Display omitted] •First report, which examine the effect of GA on gut microbiota in adenine-induced CKD.•Reno-protective effect of GA through the improvement of gut microbial dysbiosis.•GA supplementation increased the butyrate level in adenine-induced CKD animal model.•GA modulated Actinobacteria, Proteobacteria, Tenericutes and Verrucomicrobia in CKD rats. Chronic kidney disease (CKD) is a globally common and important disease and there are evidence for a bidirectional relationship between microbiota and CKD. The aim of the study was to examine the influence of prebiotic – gum acacia (GA) on the intestinal microbiota in rats with adenine-induced CKD. Animals were randomly distributed into four equal groups (n = 6): control, adenine, GA and adenine + GA groups. CKD was induced by adenine (0.75% w/w) given in the diet daily for four weeks, and GA was administered in drinking water at a concentration of 15% w/v. The 16s rRNA analysis was performed on Illumina Miseq targeting V3-V4 region to characterize microbial composition. The abundance of Actinobacteria, Proteobacteria, Tenericutes and Verrucomicrobia bacteria was increased in adenine-induced CKD, and GA treatment successfully reversed those levels. Interestingly, alpha and beta diversity index were both reduced with GA treatment in rats with CKD. Short chain fatty acids (SCFAs) measurement and PICRUSt analysis have shown that GA treatment completely restored the depleted butyrate level and various perturbated functional pathways, respectively, in CKD rats. Taking together, our results suggest that GA supplementation has a beneficial role in treating CKD, through an increased production of butyrate, as well as its anti-inflammatory, antioxidant capacity and anti-nitrosative properties.
ISSN:0753-3322
1950-6007
DOI:10.1016/j.biopha.2020.110992